Dr. Ritchie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2093 Philadelphia Pike #2696
Claymont, DE 19703Fax+1 218-228-0904
Education & Training
- University of LouisvilleCertificate, Biostatistics, 2021 - 2023
- University of MarylandResidency, Dermatology, 2010 - 2013
- David Grant Medical CenterInternship, Transitional Year, 2007 - 2008
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2007
Certifications & Licensure
- FL State Medical License 2022 - Present
- CA State Medical License 2022 - 2026
- WA State Medical License 2023 - 2026
- TN State Medical License 2024 - 2026
- ND State Medical License 2022 - 2026
- NY State Medical License 2022 - 2026
- WY State Medical License 2022 - 2025
- American Board of Dermatology Dermatology
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsBullous pemphigoid treated with intravenous immunoglobulin.Papapit Tuchinda, Simon Ritchie, Anthony A. Gaspari
Cutis. 2014-05-01 - 3 citationsSpread of vaccinia virus through shaving during military training, Joint Base San Antonio-Lackland, TX, June 2014.Bryant J Webber, Montgomery, Ana E Markelz, Allen Kc, John Hunninghake
MSMR. 2014-08-01 - 14 citationsA phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasisSimon Ritchie, Danielle Neal, Harold Shlevin, Adam Allgood, Peter G. Traber
Journal of the American Academy of Dermatology. 2017-10-01
Press Mentions
- GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)March 14th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: